4000 Glaciers Vanish Annually, Moderna Expands Europe After EMA Endorsement, FDA Approves Breakthrough HER2 Therapy, Anixa Drives Breast Cancer Vaccine Trials, and more...

(0:10): Climate Crisis: 4,000 Glaciers Could Vanish Annually by 2030s, Urgent Mitigation Needed(2:48): Moderna's mNEXSPIKE Set for European Expansion Following EMA Endorsement(4:43): FDA Approves ENHERTU Combo as Breakthrough First-Line Therapy for HER2-Positive Breast Cancer(7:22): Anixa Biosciences Takes Helm of Breast Cancer Vaccine Trials, Eyes Phase 2 Expansion(9:29): First-Ever Runaway Supermassive Black Hole Confirmed, Leaves 200,000 Light-Year Tail and Supersonic Bow ShockTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: WELT